DOC PREVIEW
UWEC CHEM 412 - Attention-Deficit Hyperactivity Disorder

This preview shows page 1-2-21-22 out of 22 pages.

Save
View full document
View full document
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience
View full document
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience
Premium Document
Do you want full access? Go Premium and unlock all 22 pages.
Access to all documents
Download any document
Ad free experience

Unformatted text preview:

Attention-Deficit Hyperactivity DisorderADHD StatisticsOutlineHistory of ADHDDiagnosing ADHD: DSM-IVSlide 6Slide 7Problems of DiagnosisADHD and the BrainADHD and the Brain IIWhat causes ADHD?Dopamine in the BrainGenetic Linkages to ADHDDRD4TreatmentStimulantsMethylphenidateEffects of MPHSide EffectsOutcomeReferencesSlide 22Attention-Deficit Hyperactivity DisorderByChris GolnerApril 19, 1999Biochemistry/Molecular Biology SeminarADHD Statistics3-5% of all U.S. school-age children are estimated to have this disorder.5-10% of the entire U.S. populationMales are 3 to 6 times more likely to have ADHD than are females.At least 50% of ADHD sufferers have another diagnosable mental disorder.OutlineHistory of ADHDSymptoms and Diagnosis: DSM-IV criteriaPossible causesTreatmentsStimulants OutcomeHistory of ADHDMid-1800s: Minimal Brain DamageMid 1900s: Minimal Brain Dysfunction1960s: Hyperkinesia1980: Attention-Deficit DisorderWith or Without Hyperactivity1987: Attention Deficit Hyperactivity Disorder1994-present: ADHD Primarily InattentivePrimarily HyperactiveCombined TypeDiagnosing ADHD: DSM-IV Inattentiveness:Has a minimum of 6 symptoms regularly for the past six months.Symptoms are present at abnormal levels for stage of developmentLacks attention to detail; makes careless mistakeshas difficulty sustaining attentiondoesn’t seem to listenfails to follow through/fails to finish projectshas difficulty organizing tasksavoids tasks requiring mental effortoften loses items necessary for completing a taskeasily distracted is forgetful in daily activitiesDiagnosing ADHD: DSM-IVHyperactivity/ Impulsivity:Fidgets or squirms excessivelyleaves seat when inappropriateruns about/climbs extensively when inappropriatehas difficulty playing quietlyoften “on the go” or “driven by a motor”talks excessivelyblurts out answers before question is finishedcannot await turninterrupts or intrudes on othersHas a minimum of 6 symptoms regularly for the past six months.Symptoms are present at abnormal levels for stage of developmentDiagnosing ADHD: DSM-IVAdditional Criteria:Symptoms causing impairment present before age 7Impairment from symptoms occurs in two or more settingsClear evidence of significant impairment (social, academic, etc.)Symptoms not better accounted for by another mental disorderProblems of DiagnosisSubjectivity of CriteriaInconsistent evaluations--presence of symptoms usually given by teacher or parentStudy by Szatmari et al (1989) showed that the number of diagnosed cases of ADHD decreased 80% when observations of parent, teacher and physician were used rather than just one sourceSymptoms in females more subtle---leads to underdiagnosisADHD and the BrainDiminished arousal of the Nervous SystemDecreased blood flow to prefrontal cortex and pathways connecting to limbic system (caudate nucleus and striatum)PET scan shows decreased glucose metabolism throughout brainComparison of normal brain (left) and brain of ADHD patient.ADHD and the Brain IISimilarities of ADHD symptoms to those from injuries and lesions of frontal lobe and prefrontal cortexMRIs of ADHD patients show:Smaller anterior right frontal lobeabnormal development in the frontal and striatal regionsSignificantly smaller splenium of corpus callosumdecreased communication and processing of information between hemispheresSmaller caudate nucleusWhat causes ADHD?Underlying cause of these differences is still unknown; there is much conflicting data between studiesStrong evidence of genetic componentPredominant theory: Catecholamine neurotransmitter dysfunction or imbalancedecreased dopamine and/or norepinephrine uptake in braintheory supported by positive response to stimulant treatment Recent study indicates possible lack of serotonin as a factor in miceScientific AmericanHttp//www.sciam.com/1998/0998issue/0998barkely.html#link1Dopamine in the BrainGenetic Linkages to ADHDTwin studies by Stevenson, Levy et al, and Sherman et al indicate an average heritability factor of .80Biederman et al reported a 57% risk to offspring if one parent has ADHD. Dopamine genesDA type 2 geneDA transporter gene (DAT1)Dopamine receptor (DRD4, “repeater gene”) is over-represented in ADHD patientsDRD4DRD4 is most likely contributorDRD4 affects the post-synaptic sensitivity in the prefrontal and frontal cortexThis region of cortex affects executive functions and attentionExecutive functions include working memory, internalization of speech, emotions, motivation, and learning of behaviorTreatmentCounseling of individual and familyStimulants Tricyclic antidepressantsBupropion ClonidineStimulantsExact mechanism unknownRaise activity level of the CNS by decreasing fluctuations of activity or lowering threshold needed for arousalSimilar in structure to NE and DA, and may mimic their actionsAt least 75% have positive response with single dose95% respond well to stimulant treatmentInclude methylphenidate, dextroamphetamine and pemolineMethylphenidateIs a piperidine derivative commonly known as Ritalin®Is believed to act as dopamine agonist in synaptic cleftStimulates frontal-striatal regionsDosage (5-20 mg) must be adjusted to each patientTaken orally, 2-3 times a day as neededBehavioral effects start within 1/2 hour to hour after ingestion, peaking at 1 and 3 hoursAlso comes in Sustained-Release form, whose effects last approximately twice as long.Effects of MPHElevates moodRaises arousal of CNS and cerebral blood flowIncreases productivityImproves social interactionsIncreases heart rate and blood pressureHas little or no abuse potentialSide EffectsCommon:decreased appetiteinsomniabehavioral reboundhead and stomach achesAlso thought to cause temporary height and weight suppressionMild:anxiety/ depressionirritabilityRare:tics (Tourette’s Syndrome)overfocussingliver problems or rash (Pemoline only)OutcomeADHD can persist into adulthood, but usually symptoms gradually diminishWhen it persists into adulthood, it usually requires ongoing treatment and counselingmost will develop another disorder (especially learning disability, ODD, depression, and/or conduct disorder)Without treatment:antisocial and


View Full Document

UWEC CHEM 412 - Attention-Deficit Hyperactivity Disorder

Download Attention-Deficit Hyperactivity Disorder
Our administrator received your request to download this document. We will send you the file to your email shortly.
Loading Unlocking...
Login

Join to view Attention-Deficit Hyperactivity Disorder and access 3M+ class-specific study document.

or
We will never post anything without your permission.
Don't have an account?
Sign Up

Join to view Attention-Deficit Hyperactivity Disorder 2 2 and access 3M+ class-specific study document.

or

By creating an account you agree to our Privacy Policy and Terms Of Use

Already a member?